|
|
|
Preclinical Pharmacology and Toxicology
|
 |
| |
|
Other Categories
|
Consultation on Drug Discovery and Development
Gastrointestinal Disorders: stomach emptying rate in rat, castor oil-induced diarrhea in rat, cholera toxin-induced enterectasis in mouse, intestinal motility in mouse or rat, dextran sulfate sodium-induced inflammatory bowel disease in mouse or rat
General Compound Characterization: conditioned taste aversion in rat, locomotor activity in mouse or rat, chronic locomotor activity in high-value transgenic mouse (repeated measures design), conditioned avoidance retention in rat, acoustic startle response in mouse or rat, electrical self-stimulation of brain in rat, modified Irwin, kappa opioid agonist-induced diuresis in rat, 8-OH-DPAT-induced flattened body posture and lip retraction in rat (5HT1a antagonism), DOI-induced head shakes in rat (5-HT2a antagonism), potentiation of 5-HTP-induced wet dog shakes in rat (5-HT uptake inhibition), other drug interactions, blood sample for pharmacokinetics in mouse or rat
Hypnotics and Pre-Anesthetics: sleeping time in rat
Muscle Spasm: morphine-induced rigidity and Straub tail in mouse or rat
Obesity and Diabetes: reduction of body weight in genetically obese mouse or rat, food consumption, insulin and glucose levels
Parkinson's Disease: haloperidol-induced catalepsy in rat
|
|
|
|
